393 related articles for article (PubMed ID: 21222556)
1. Drug release from liquisolid systems: speed it up, slow it down.
Nokhodchi A; Hentzschel CM; Leopold CS
Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
[TBL] [Abstract][Full Text] [Related]
2. Liquisolid Technology: A State-of-the-Art Review on the Current State, Challenges, New and Emerging Technologies for Next Generation.
Agiba AM
Curr Drug Deliv; 2020; 17(9):736-754. PubMed ID: 32729418
[TBL] [Abstract][Full Text] [Related]
3. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of griseofulvin release from liquisolid compacts.
Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
[TBL] [Abstract][Full Text] [Related]
5. Liquisolid systems and aspects influencing their research and development.
Vraníková B; Gajdziok J
Acta Pharm; 2013 Dec; 63(4):447-65. PubMed ID: 24451071
[TBL] [Abstract][Full Text] [Related]
6. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
Hentzschel CM; Sakmann A; Leopold CS
Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
[TBL] [Abstract][Full Text] [Related]
7. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
[TBL] [Abstract][Full Text] [Related]
8. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
9. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
Javadzadeh Y; Musaalrezaei L; Nokhodchi A
Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
[TBL] [Abstract][Full Text] [Related]
10. A Technical Approach of Solubility Enhancement of Poorly Soluble Drugs: Liquisolid Technique.
Chaudhary N; Tripathi D; Rai AK
Curr Drug Deliv; 2020; 17(8):638-650. PubMed ID: 32416691
[TBL] [Abstract][Full Text] [Related]
11. Liquisolid technology for dissolution rate enhancement or sustained release.
Karmarkar AB; Gonjari ID; Hosmani AH
Expert Opin Drug Deliv; 2010 Oct; 7(10):1227-34. PubMed ID: 20731614
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
[TBL] [Abstract][Full Text] [Related]
13. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
14. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
Khanfar M; Sheikh Salem M; Hawari R
Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
[TBL] [Abstract][Full Text] [Related]
15. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
Badawy MA; Kamel AO; Sammour OA
Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
[TBL] [Abstract][Full Text] [Related]
16. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
Bikiaris DN
Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
[TBL] [Abstract][Full Text] [Related]
17. BCS class IV drugs: Highly notorious candidates for formulation development.
Ghadi R; Dand N
J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
[TBL] [Abstract][Full Text] [Related]
18. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
[TBL] [Abstract][Full Text] [Related]
19. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
Fahmy RH; Kassem MA
Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
